Bristol-Myers Squibb | Aktywa



Current Assets Zmiana Data
AbbVie USD 27.68B 2.09B 2025-03
Abbott USD 24.47B 1.32B 2025-06
ALKERMES USD 1.64B 156.24M 2025-06
Amgen USD 26.73B 195M 2025-06
AstraZeneca USD 28.94B 2.8B 2025-06
Biogen USD 7.97B 341.7M 2025-06
Bristol-Myers Squibb USD 33.22B 2.44B 2025-06
Drreddys Laboratories INR 253.02B 4.89B 2024-12
Eli Lilly USD 49.85B 8.59B 2025-06
Gilead Sciences USD 14.72B 2.18B 2025-06
GlaxoSmithKline GBP 17.67B 412M 2025-06
J&J USD 71.55B 15.66B 2025-03
Medtronic USD 23.81B 1.3B 2025-04
Merck USD 37.07B 1.56B 2025-06
Novartis USD 25.94B 831M 2025-06
Novo Nordisk 162.71B 11.69B 2025-06
Perrigo USD 2.62B 82M 2025-06
Pfizer USD 43.7B 2.16B 2025-06
Prestige Brands USD 480.52M 32.19M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Roche Holding CHF 40.04B 6.41B 2024-12
Sanofi 37.02B 7B 2025-06
Sanofi 42.59B 12.51B 2024-12
United Therapeutics USD 3.83B 112.9M 2025-06
Zoetis USD 5.92B 46M 2025-06


Bristol-Myers Squibb Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.